Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil-Reference-Cited by-同舟云学术

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil

Published:2018-12-06 Issue: Volume:9 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Takashita Emi,Morita Hiroko,Ogawa Rie,Nakamura Kazuya,Fujisaki Seiichiro,Shirakura Masayuki,Kuwahara Tomoko,Kishida Noriko,Watanabe Shinji,Odagiri Takato

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference22 articles.

1. Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.;Abed;PLoS Pathog.,2011

2. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.;Abed;J. Virol.,2014

3. Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies.;Barnett;Antimicrob. Agents Chemother.,2000

4. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.;Bloom;Science,2010

5. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase.;Bouvier;J. Virol.,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir;Archives of Virology;2024-01-12

2. Prophylactic Treatment with Baloxavir Protects Mice from Lethal Infection with Influenza A and B Viruses;Viruses;2023-11-16

3. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate;iScience;2023-11

4. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility;Journal of Virology;2023-07-27

5. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022;International Journal of Molecular Sciences;2023-04-23